Ronald Peeters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ronald Peeters has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Dupont
Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI), Belgium; and
6 shared publications - Frederik Maes
KU Leuven
4 shared publications - Kristl G. Claeys
Department of Neurology University Hospitals Leuven Leuven Belgium
4 shared publications - Lotte Huysmans
Department ESAT/PSI, KU Leuven, Belgium
4 shared publications - Louise Iterbeke
Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI) and Leuven Institute for Rare Diseases (Leuven.IRD), Belgium
4 shared publications - Kirstin-Friederike Heise
Department of Health Sciences and Research, Medical University of South Carolina, Charleston, SC, USA
3 shared publications
Latest Publications
- 22 December 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (12)
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
- 22 December 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (12)
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
- Open Access
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218411
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
Background and ObjectivesCharcot-Marie-Tooth neuropathy type 1A (CMT1A) is a slowly progressive demyelinating neuropathy with distal muscle weakness and atrophy. Sensitive, objective outcome measur...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218411
Open AccessQuantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes
Background and ObjectivesCharcot-Marie-Tooth neuropathy type 1A (CMT1A) is a slowly progressive demyelinating neuropathy with distal muscle weakness and atrophy. Sensitive, objective outcome measur...
- Open Access
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218349
Natural History of Adult-Onset Myotonic Dystrophy Type 1
Background and ObjectivesAdult-onset myotonic dystrophy type 1 (DM1) is a progressive, multisystemic disorder, characterized by distal muscle weakness and myotonia. As disease-modifying therapies e...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218349
Open AccessNatural History of Adult-Onset Myotonic Dystrophy Type 1
Background and ObjectivesAdult-onset myotonic dystrophy type 1 (DM1) is a progressive, multisystemic disorder, characterized by distal muscle weakness and myotonia. As disease-modifying therapies e...
- Open Access
- 1 August 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (8)
3D Radiomic Texture Analysis of Quantitative Muscle MRI Enhances the Distinction Between Myotonic Dystrophy Type 1 and Charcot–Marie‐Tooth Neuropathy Type 1A : A Proof‐of‐Concept Study
Background: Differentiating myogenic from neurogenic neuromuscular diseases (NMDs) can be clinically challenging. While quantitative muscle MRI (qMRI) with proton density fat fraction (PDFF,%) quantifies fat replacement, it misses micro‐spatial patterns linked to underlying pathology. This study investigates whether qMRI with 3D radiomic texture analysis (TA) might improve differentiation between myogenic and neurogenic diseases, using myotonic dystrophy type 1 (DM1) and Charcot–Marie‐Tooth neuropathy type 1A (CMT1A) as proof‐of‐concept models. Methods: Thirty‐three adults with DM1, 33 with CMT1A, and 33 matched healthy controls were included. qMRI on a 3T Philips Achieva system using a 6‐point Dixon sequence generated PDFF(%) maps of the lower limbs, and a convolutional neural network performed 3D segmentation of 28 lower limb muscles. We extracted macroscopic features, including muscle volume, asymmetry, and disto‐proximal gradients, alongside micro‐spatial radiomic features (entropy, contrast, homogeneity) to quantify tissue heterogeneity. Results: Both patient cohorts exhibited higher PDFF(%) in all lower limb muscles compared to controls ( p < 0.001). DM1 predominantly involved the posterior compartment, while CMT1A targeted the anterolateral compartment with significantly steeper disto‐proximal fat gradients ( p < 0.05). TA revealed higher entropy and contrast, and lower homogeneity in CMT1A compared to DM1, reflecting a more reticular pattern of fat infiltration vs. the confluent pattern in DM1. Conclusion: In this proof‐of‐concept study, 3D radiomic texture analysis of PDFF(%) maps revealed distinct spatial patterns of fat replacement in DM1 and CMT1A. Integrating radiomic and conventional qMRI features may enhance the non‐invasive distinction between DM1 and CMT1A and warrants further investigation in a broader range of NMDs.
- 1 August 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (8)
Open Access3D Radiomic Texture Analysis of Quantitative Muscle MRI Enhances the Distinction Between Myotonic Dystrophy Type 1 and Charcot–Marie‐Tooth Neuropathy Type 1A : A Proof‐of‐Concept Study
Background: Differentiating myogenic from neurogenic neuromuscular diseases (NMDs) can be clinically challenging. While quantitative muscle MRI (qMRI) with proton density fat fraction (PDFF,%) quantifies fat replacement, it misses micro‐spatial patterns linked to underlying pathology. This study investigates whether qMRI with 3D radiomic texture analysis (TA) might improve differentiation between myogenic and neurogenic diseases, using myotonic dystrophy type 1 (DM1) and Charcot–Marie‐Tooth neuropathy type 1A (CMT1A) as proof‐of‐concept models. Methods: Thirty‐three adults with DM1, 33 with CMT1A, and 33 matched healthy controls were included. qMRI on a 3T Philips Achieva system using a 6‐point Dixon sequence generated PDFF(%) maps of the lower limbs, and a convolutional neural network performed 3D segmentation of 28 lower limb muscles. We extracted macroscopic features, including muscle volume, asymmetry, and disto‐proximal gradients, alongside micro‐spatial radiomic features (entropy, contrast, homogeneity) to quantify tissue heterogeneity. Results: Both patient cohorts exhibited higher PDFF(%) in all lower limb muscles compared to controls ( p < 0.001). DM1 predominantly involved the posterior compartment, while CMT1A targeted the anterolateral compartment with significantly steeper disto‐proximal fat gradients ( p < 0.05). TA revealed higher entropy and contrast, and lower homogeneity in CMT1A compared to DM1, reflecting a more reticular pattern of fat infiltration vs. the confluent pattern in DM1. Conclusion: In this proof‐of‐concept study, 3D radiomic texture analysis of PDFF(%) maps revealed distinct spatial patterns of fat replacement in DM1 and CMT1A. Integrating radiomic and conventional qMRI features may enhance the non‐invasive distinction between DM1 and CMT1A and warrants further investigation in a broader range of NMDs.
- Open Access
- 16 December 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 37
Development and validation of a novel patient-specific 3D-printed head and neck immobilization device for radiotherapy
- 16 December 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 37
Open AccessDevelopment and validation of a novel patient-specific 3D-printed head and neck immobilization device for radiotherapy
- Open Access
- 31 March 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (3) , 756-767
Induced zero-phase synchronization as a potential neural code for optimized visuomotor integration
- 31 March 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (3) , 756-767
Open AccessInduced zero-phase synchronization as a potential neural code for optimized visuomotor integration
- 26 February 2022
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 39 (3) , 479-493
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology
To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics.
- 26 February 2022
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 39 (3) , 479-493
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology
To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics.
- 21 February 2022
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 59, 102532
Reliability and agreement of lumbar multifidus volume and fat fraction quantification using magnetic resonance imaging
- 21 February 2022
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 59, 102532
Reliability and agreement of lumbar multifidus volume and fat fraction quantification using magnetic resonance imaging
- 4 December 2021
- Published by Springer Nature
- p. 407-439
Clinical BOLD fMRI and DTI: Artifacts, Tips, and Tricks
- 4 December 2021
- Published by Springer Nature
- p. 407-439
Clinical BOLD fMRI and DTI: Artifacts, Tips, and Tricks
- Open Access
- 1 December 2021
- Published by Elsevier in Physics in Medicine
- Vol. 12
Reproducibility of T1 relaxation times in diagnostic MRI: A phantom study
- 1 December 2021
- Published by Elsevier in Physics in Medicine
- Vol. 12
Open AccessReproducibility of T1 relaxation times in diagnostic MRI: A phantom study